%20(3)_edited_edited_edi.png)
Let Your Data Drive Your Clinical Research
At CiNTL Pharma, we understand the importance of data in clinical research.
We use agentic workflows that connect science, data, and execution, helping sponsors deliver therapies to patients faster, safer, and smarter.
We provide customized solutions to meet the unique needs of each client, ensuring that their research is conducted efficiently and effectively and to the highest degree of integrity.
_edited.png){kind=small}
Versatility in Clinical Research Applications
CiNTL Pharma provides a wide range of clinical research services, including medical writing, regulatory submissions, clinical monitoring, and site management. We have experience working with a variety of therapeutic areas and study designs, and we are committed to delivering high-quality results.
Full-Service Clinical Research Solutions
Offering end-to-end clinical research solutions, from study design to final report. Our team of experts has extensive experience in managing clinical trials and can provide customized solutions to meet our clients' unique needs.
Cloud Analytics for Clinical Research
Our cloud analytics platform enables our clients to securely store and analyze their clinical data in real-time. This allows for faster decision-making and more efficient clinical trials. Our platform is fully compliant with industry regulations and standards.
Data Science for Clinical Research
Our team of data scientists specializes in clinical research and provides advanced statistical analysis and modeling. We help our clients make sense of their data, identify trends, and make data-driven decisions.
Unprecedented Velocity. Impeccable Reliability.
CiNTL Pharma is committed to providing our clients with high-quality outsourced clinical research services. Our team of experts uses the latest technology to drive speed and delivery. Offer a wide range of services, including R&D, risk-based clinical monitoring, project and data management, statistical analysis, from inception to completion. Complex clinical trials projects are our forte.
The Latest at CiNTL Pharma
-2_edited.png){kind=small}
-2.jpg){kind=small}
08 - Jan - 2026
CiNTL Pharma B.V. today announced that has joined Utrecht Leading Life Sciences Hub, marking an important milestone in the company’s continued growth. We are proud to be among the first tenants of the newly completed Plus Ultra Utrecht, developed by Kadans Science Partner, and awarded the BREEAM-NL Outstanding certification, the highest sustainability rating for buildings in the Netherlands.
​
Operating from Utrecht Science Park strengthens our ability to work closely with innovators, researchers, and industry partners translating scientific advances into real-world outcomes that matter to patients and healthcare systems.
​
As we begin the year ahead, we welcome conversations with organizations exploring partnerships, advisory support, or strategic collaboration, and look forward to contributing to the continued strength of the Utrecht life sciences ecosystem.​​​​​​​​​
16 - Oct - 2025
CiNTL Pharma B.V. today announced the development of an integrated agentic platform designed to reshape how pharmaceutical and biotechnology companies design, manage, and monitor clinical trials across all phases of development.
CiNTL Pharma’s innovation addresses one of the industry’s most persistent challenges, disconnected systems and fragmented data. “For too long, systems haven’t talked, insights have been lost, and outsourcing providers rarely listen to the professionals who actually run the work,” said Yolanda Cabrera-Sybesma, CEO, CiNTL Pharma B.V. “The gaps are huge, the systems are fragmented, and innovation often stops where it should start, with data. We know, first hand that it can be done better.”
​
​By aligning science, data, and execution through agentic workflows, CiNTL Pharma helps sponsors and life sciences leaders gain full visibility into their operations, reducing waste, improving collaboration, and strengthening regulatory readiness.
​
10 - Jul - 2025
CiNTL Pharma B.V. and SmartCatch Announce Strategic Partnership to Advance Agentic AI in Clinical Research and Oncology Diagnostics. Uniting CiNTL Pharma’s vision for agentic software in clinical trial design and execution with SmartCatch’s pioneering X-Tracker™ technology, a fully automated, label-free platform that isolates viable CTCs from whole blood, enabling unprecedented insight into tumor biology and treatment response.
“Partnering with CiNTL Pharma is a natural extension of our mission to make CTCs a clinical reality,” added Dr. Eline Cerf, Co-Founder and CEO of SmartCatch. “Together, we aim to redefine how oncology trials are monitored, optimized, and scaled, with real-time biological insight at the core.”
​
“We are excited to join forces with SmartCatch to accelerate the future of personalized oncology and agentic CRO models,” said Yolanda Cabrera-Sybesma, CEO of CiNTL Pharma B.V.
It's all about the data
25+
Years of Experience
180
Pre-Clinical, Phase I-IV
80,000
Patients Enrolled
8
Therapeutic Areas
5
Continents
Meet Us at an Event
